Clinical trial
Effects of Maintaining Steady Albumin Levels by Targeted Albumin Therapy (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites and Low Serum Albumin Level- a Randomized Controlled Trial
NCT04058613 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Maintaining Steady Albumin Levels by Targeted Albumin Therapy (TAT 4) on Survival and Liver Related Complications in Cirrhosis With Ascites and Low Serum Albumin Level- a Randomized Controlled Trial
- Lead sponsor
- Institute of Liver and Biliary Sciences, India
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 10, 2019
- Completion date
- August 8, 2021
- Enrollment
- 304 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.